For Stan Glantz:

The CDC has done enough damage with its irresponsible and untruthful propaganda about electronic cigarettes. It is time that policy decisions be guided by science rather than politics. And the science is now in. It indicates that youth smoking levels are at record lows, which casts serious doubt on the hypothesis that electronic cigarettes are fueling an alarming increase in youth smoking.

Think of it this way: Individual X has smoked 2 packs per day for 30 years. She has tried, unsuccessfully, to quit smoking using the nicotine patch and nicotine gum. Finally, she has successfully quit smoking using electronic cigarettes.

The rest of the story is that none of these studies examined quit rates among smokers who were trying to quit using e-cigarettes. None of these studies were in fact designed to examine the role of e-cigarettes in smoking cessation in the first place.

Dr. Benowitz: "Dr. Benowitz, as a paid consultant for pharmaceutical companies, has assisted them with the design, development, and marketing of smoking-cessation products. Among the companies for which he has consulted on such products are GlaxoSmithKline plc and its affiliates (collectively, “GSK”); Pfizer, Inc. and its affiliates (collectively, “Pfizer”); Novartis AG and its affiliates (collectively, “Novartis”); Sanofi-Aventis U.S. LLC and its affiliates (collectively, “Sanofi-Aventis”); and Aradigm Corp. and its affiliates (collectively, “Aradigm”). During the last ten years, he has received at least approximately $10,000 per year for such consulting. He has also received grant support for research and writing from GSK and/or Pfizer on at least five occasions. In 2010, he co-authored a study, funded by Pfizer, on the use of its drug, Chantix, for smoking cessation."

LAST：EGO CE5 With CE5 Clearomizer 2.4ml Replaceable Coil Head King One Factory wholesale EGO CE5 |NEXT：colorful 510/ego/ce4 atomizer drip tip new products for 2013